NLRP3 and coronary artery disorder: To validate the clinical relevance of NLRP3, we performed plasma proteomics in coronary heart disease (CHD) patients and non-CHD controls, which revealed significant enrichment of the NLRP3 inflammasome, IL-18 receptor complex, and pyroptosis pathways in CHD patients (supplementary Fig. 3a, b).